Evolving frequency and outcomes of liver transplantation based on etiology of liver disease

Transplantation

Volumn 95, Issue 5, 2013, Pages 755-760

  Singal, Ashwani K ^a   Guturu, Praveen ^b   Hmoud, Bashar ^b   Kuo, Yong Fang ^b   Salameh, Habeeb ^b   Wiesner, Russell H ^a  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

Graft survival; Mortality; Orthotropic liver transplantation; UNOS

Indexed keywords

ADULT; ALCOHOL LIVER CIRRHOSIS; ARTICLE; BILIARY CIRRHOSIS; FEMALE; GRAFT SURVIVAL; HEPATITIS B; HEPATITIS C; HUMAN; KIDNEY TRANSPLANTATION; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER DISEASE; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; OUTCOME ASSESSMENT; PREDICTION; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; SURVIVAL; FATTY LIVER; LIVER TUMOR; MORTALITY; PROPORTIONAL HAZARDS MODEL; STATISTICS; TREATMENT OUTCOME;

ADULT; FATTY LIVER; GRAFT SURVIVAL; HUMANS; LIVER CIRRHOSIS, BILIARY; LIVER DISEASES; LIVER NEOPLASMS; LIVER TRANSPLANTATION; PROPORTIONAL HAZARDS MODELS; TREATMENT OUTCOME;

MLCS; MLOWN;

EID: 84877280092     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e31827afb3a     Document Type: Article

References (31)

1. Lim KB, Schiano TD. Long-term outcome after liver transplantation. Mount Sinai J Med 2012; 79: 169.
2. Wiesner RH, Rakela J, Ishitani MB, et al. Recent advances in liver transplantation. Mayo Clinic Proc 2003; 78: 197.
3. Wertheim JA, Petrowsky H, Saab S, et al. Major challenges limiting liver transplantation in the United States. Am J Transplant 2011; 11: 1773.
4. Kamath PS, Wiesner RH, Malinchoc M, et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001; 33: 464.
5. Wiesner R, Edwards E, Freeman R, et al. Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology 2003; 124: 91.
6. Feng S, Goodrich NP, Bragg-Gresham JL, et al. Characteristics associated with liver graft failure: the concept of a donor risk index. Am J Transplant 2006; 6: 783.
7. Kotlyar DS, Burke A, Campbell MS, et al. A critical review of candidacy for orthotopic liver transplantation in alcoholic liver disease. Am J Gastroenterol 2008; 103: 734.
8. Julapalli VR, Kramer JR, El-Serag HB. Evaluation for liver transplantation: adherence to AASLD referral guidelines in a large Veterans Affairs center. Liver Transpl 2005; 11: 1370.
9. Burra P, Senzolo M, Adam R, et al. Liver transplantation for alcoholic liver disease in Europe: a study from the ELTR (European Liver Transplant Registry). Am J Transplant 2010; 10: 138.
10. Lucey MR, Schaubel DE, Guidinger MK, et al. Effect of alcoholic liver disease and hepatitis C infection on waiting list and posttransplant mortality and transplant survival benefit. Hepatology 2009; 50: 400.
11. Mathurin P, Moreno C, Samuel D, et al. Early liver transplantation for severe alcoholic hepatitis. N Engl J Med 2011; 365: 1790.
12. Singal AK, Bashar H, Anand BS, et al. Outcomes after liver transplantation for alcoholic hepatitis are similar to alcoholic cirrhosis: exploratory analysis from UNOS database. Hepatology 2012; 55: 1398.
13. O'Leary JG, Lepe R, Davis GL. Indications for liver transplantation. Gastroenterology 2008; 134: 1764.
14. Charlton MR, Burns JM, Pedersen RA, et al. Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States. Gastroenterology 2011; 141: 1249.
15. Kim WR, Benson JT, Hindman A, et al. Decline in the need for liver transplantation for end stage liver disease secondary to hepatitis B in the US. Hepatology 2007; 46: 238A.
16. Lee J, Belanger A, Doucette JT, et al. Transplantation trends in primary biliary cirrhosis. Clin Gastroenterol Hepatol 2007; 5: 1313.
17. Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996; 334: 693.
18. Davis CL, Feng S, Sung R, et al. Simultaneous liver-kidney transplantation: evaluation to decision making. Am J Transplant 2007; 7: 1702.
19. Kim WR, Poterucha JJ, Porayko MK, et al. Recurrence of nonalcoholic steatohepatitis following liver transplantation. Transplantation 1996; 62: 1802.
20. Singal AK, Watt KD, Heimbach JH, et al. Recurrence of metabolic syndrome and non-alcoholic steatohepatitis after liver trans-plantationVa comparative analysis. Hepatology 2012; 56(suppl): 499A.
21. Afzali A, Berry K, Ioannou GN. Excellent posttransplant survival for patients with nonalcoholic steatohepatitis in the United States. Liver Transpl 2012; 18: 29.
22. Carbone M, Neuberger J. Liver transplantation in PBC and PSC: indications and disease recurrence. Clin Res Hepatol Gastroenterol 2011; 35: 446.
23. Markowitz JS, Martin P, Conrad AJ, et al. Prophylaxis against hepatitis B recurrence following liver transplantation using combination lami-vudine and hepatitis B immune globulin. Hepatology 1998; 28: 585.
24. Seehofer D, Berg T. Prevention of hepatitis B recurrence after liver transplantation. Transplantation 2005; 80: S120.
25. DiMartini A, Dew MA, Day N, et al. Trajectories of alcohol consumption following liver transplantation. Am J Transplant 2010; 10: 2305.
26. Lucey MR. Liver transplantation in patients with alcoholic liver disease. Liver Transpl 2011; 17: 751.
27. Bellamy CO, DiMartini AM, Ruppert K, et al. Liver transplantation for alcoholic cirrhosis: long term follow-up and impact of disease recurrence. Transplantation 2001; 72: 619.
28. Watt KD, Pedersen RA, Kremers WK, et al. Evolution of causes and risk factors for mortality post-liver transplant: results of the NIDDK long-term follow-up study. Am J Transplant 2010; 10: 1420.
29. Gane EJ, Portmann BC, Naoumov NV, et al. Long-term outcome of hepatitis C infection after liver transplantation. N Engl J Med 1996; 334: 815.
30. Triantos C, Samonakis D, Stigliano R, et al. Antiviral therapy for recurrent hepatitis C infection after liver transplantation. Transplantation 2005; 80: 540. (Pubitemid 41209427)
31. Aguilera V, Berenguer M, Rubin A, et al. Cirrhosis of mixed etiology (hepatitis C virus and alcohol): posttransplantation outcomeV comparison with hepatitis C virus-related cirrhosis and alcoholic-related cirrhosis. Liver Transpl 2009; 15: 79.